Identify Biomarkers in Migraine and Cluster Headache by Improving Experimental Design
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Acknowledgements
This is a highlights summary of an oral session given at the AHSAM 2020 Virtual Annual Scientific Meeting and presented by:
Simona Denise Frederiksen, PhD, MS
University of Calgary, Cumming School of Medicine
Calgary, Alberta
The content is produced by Infomedica, the official reporting partner of ASHAM 2020 Virtual Annual Scientific Meeting. The summary text was drafted by Goldcrest Medical Writing, reviewed by Marco Vercellino, MD, an independent external expert, and approved by Jessica Ailani, MD, FAHS and Mark J. Burish, MD, PhD, the scientific editors of the program.
The presenting authors of the original session had no part in the creation of this conference highlights summary.
References
1. Frederiksen SD, Bekker-Nielsen Dunbar M, Snoer AH, et al. Serotonin and neuropeptides in blood from migraine and cluster headache patients in case-control and case-crossover settings: A systematic review and meta-analysis. Headache 2020;60:1132-1164.
2. Frederiksen, S.D. Promote Biomarker Discovery by Identifying Homogenous Primary Headache Subgroups. Headache: The Journal of Head and Face Pain 2019;59:797-801.
